← 홈

CGT

90개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 90개
CGTCHotBiologicstaleThomas Martin, MDPhase 1

Chimeric Antigen Receptor T cells (CAR-T, Chimeric Antigen Receptor T cells, Chimeric Antigen Receptor T cells (CAR-T) Targeting BCMA)

Multiple Myeloma; Recurrent Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 113상태 DISCONTINUED
CGTBiologicMalaysia Palm Oil BoardPhase 1

Interleukin (Interleukin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#인기#세포유전치료+3
효능 ORR 2%임상시험 60상태 ACTIVE
CGTBiologicstaleCelgenevedotin (BV) maintenance th…Phase 2

ASCT (ASCT)

Multiple Myeloma; Newly Diagnosed · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#인기#세포유전치료+5
효능 ORR 11%임상시험 59상태 RECRUITING
CGTBiologicstaleMinsk Scientific-Practical Cent…Phase 2

Anti-BCMA CAR-T cells (Anti-BCMA CAR-T cells)

Multiple Myeloma Refractory · BCMA

#BCMA#CGT#Phase2#인기#세포유전치료+5
효능 ORR 97.1%임상시험 56상태 RECRUITING
CGTBiologicstaleCarbiogene Therapeutics Co. Ltd.Phase 1

anti-BCMA CAR-T (anti-BCMA CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 55상태 ACTIVE
CGTBiologicInternational Brain Research Fo…Phase 2

Quercetin (Quercetin)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 RECRUITING
CGTBiologicMerck Sharp & Dohme LLCPhase 2

Letermovir (Letermovir)

Relapsed Refractory Multiple Myeloma (RRMM) · Cell Therapy

#CellTherapy#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 45상태 RECRUITING
CGTBiologicstaleSung-Soo ParkPreclinical

IMiD treatment (IMiD treatment)

Multiple Myeloma, Relapsed; Multiple Myeloma (MM) · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+5
효능 ORR 48.3%임상시험 39상태 RECRUITING
CGTBiologicBristol-Myers SquibbPhase 2

bb2121 (Ide-cel, Ide-cel (bb2121))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 74.5%임상시험 33상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

LCAR-B38M CAR-T Cell (LCAR-B38M CAR-T Cell)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 96.6%임상시험 22상태 DISCONTINUED
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell infusion agent targeting BCMA chimeric antigen receptor (T cell infusion agent targeting BCMA chimeric antigen receptor)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 42.9%임상시험 13상태 ACTIVE
CGTBiologicstaleAsclepius Technology Company Gr…Phase 1

Anti-BCMA CAR-NK Cells (Anti-BCMA CAR-NK Cells)

Multiple Myeloma, Refractory · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 10상태 ACTIVE
CGTBiologicstaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel (Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection, Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (Eque-cel))

Relapsed/Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 9상태 RECRUITING
CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR088 (C-CAR088)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 6상태 ACTIVE
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

APRIL CAR-T cells (APRIL CAR-T cells)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 4상태 RECRUITING
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

BCMA CAR-T (BCMA CAR-T)

Multiple Myeloma, Newly Diagnosed · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 4상태 ACTIVE
CGTBiologicstalePolina StepenskyPhase 2

HBI0101 CART (HBI0101 CART)

Multiple Myeloma, Refractory to Standard Treatment; Multiple Myeloma, Relapsed · Systemic Sclerosis (SSc)

#SystemicSclerosisSSc#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 4상태 RECRUITING
CGTBiologicstaleElvira UmyarovaPhase 1

Universal Donor Expanded TGF-beta-imprinted NK Cells (Universal Donor Expanded TGF-beta-imprinted NK Cells)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 4상태 ACTIVE
CGTBiologicstaleJuno Therapeutics, Inc., a Bris…Phase 2

Arlocabtagene Autoleucel (Arlocabtagene Autoleucel)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 RECRUITING
CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Phase 2

CAR-BCMA T Cells (CAR-BCMA T Cells)

Refractory or Relapsed Multiple Myeloma · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE

1 / 5 페이지

← 이전다음 →